CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Galaxy Digital HoldingsLtd(Pre-Reincorp) is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Galaxy Digital HoldingsLtd(Pre-Reincorp)
107 Grand St Fl 7
NEW YORK, NY  10013-5903  United States Ticker: GLXYGLXY

Business Summary
Galaxy Digital Holdings Ltd, formerly Bradmer Pharmaceuticals Inc, is a Canada-based diversified, multi-service merchant bank dedicated to the digital assets and blockchain technology industry. The Company operates the following business lines: Trading, such as arbitrage, macro and market making/Over The Counter (OTC); Asset Management, such as management of external capital across passive and ecosystem funds; Principal Investing, such as private equity, venture, public equity, Initial Coin Offering (ICO) investments, Pre-ICO investments, and liquid and illiquid cryptocurrencies, as well as Advisory, such as capital markets, Mergers and Acquisitions (M&A)/restructuring, and technical consulting services to both start-ups and established institutions.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
IRA CQ
Score
Moody's
Rating
Fitch
Rating
DBRS
Rating
Morningstar
Rating
YesYes-------

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
6/30/201912/31/2018Yes----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman of the Board, Chief Executive Officer, Founder Michael E.Novogratz
Chief Financial Officer Donna M.Milia 43
Chief Operating Officer JulieCoin
12 additional Officers and Directors records available in full report.

Business Names
Business Name
7LX
BMR
BMR.H
Bradmer Pharmaceuticals Inc.
GLXY

General Information
Number of Employees: 80 (As of 6/30/2019)
Outstanding Shares: 66,796,287 (As of 11/8/2019)
Stock Exchange: CVE


Copyright © 2019 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, November 14, 2019